By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DURECT Corporation 

2 Results Way

Cupertino  California  95014  U.S.A.
Phone: 408-777-1417 Fax: 408-777-3577



Company News
DURECT (DRRX) Announces Closing Of Public Offering Of Common Stock 4/29/2016 11:44:37 AM
DURECT (DRRX) Invites You To Join Its First Quarter 2016 Earnings Conference Call 4/29/2016 6:50:53 AM
DURECT (DRRX) Announces Pricing Of Public Offering Of Common Stock 4/26/2016 7:42:06 AM
DURECT (DRRX) Announces Proposed Public Offering Of Common Stock 4/26/2016 6:34:33 AM
DURECT (DRRX) Announces FDA Acceptance Of REMOXY NDA, PDUFA Date Of September 25, 2016 4/13/2016 5:58:24 AM
DURECT (DRRX) Falls Premarket After the FDA Asks for PERSIST Trial Amendments 4/8/2016 7:21:17 AM
DURECT Corporation (DRRX) Announces Resubmission Of REMOXY New Drug Application To The FDA 3/29/2016 9:35:37 AM
DURECT Corporation (DRRX) Announces Fourth Quarter 2015 Financial Results And Update Of Programs 3/1/2016 8:43:25 AM
DURECT Corporation (DRRX) Invites You To Join Its Fourth Quarter 2015 Earnings Conference Call 2/19/2016 6:52:32 AM
DURECT Corporation (DRRX) To Present At The BIO CEO & Investor Conference 1/29/2016 7:47:35 AM